Video

Why Is the Risk of Seizure Higher During the Peripartum Period?

Conference|AES Annual Meeting - American Epilepsy Society Annual Meeting

Sanjeev V. Thomas, MD, DM, FANA—professor of neurology, chairman of the Epilepsy Program, Sree Chitra Tirunal Institute—discusses why the risk of seizures is higher for women during the peripartum period.

Sanjeev V. Thomas, MD, DM, FANA—professor of neurology, chairman of the Epilepsy Program, Sree Chitra Tirunal Institute—discusses why the risk of seizures is higher for women during the peripartum period.

Related Videos
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule - Image credit: vchalup | stock.adobe.com
Related Content
Study Finds 4-Factor Prothrombin Complex Concentrate Offers Superior Hemostatic Efficacy to Frozen Plasma During Cardiac Surgery
April 11th 2025

Study Finds 4-Factor Prothrombin Complex Concentrate Offers Superior Hemostatic Efficacy to Frozen Plasma During Cardiac Surgery

Aislinn Antrim, Managing Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
April 11th 2025

HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma

Alana Hippensteele, Lead Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Vials labeled glp-1 with syringes, heart icon, and growth chart symbolize hormone therapy benefits - Image credit: TensorSpark | stock.adobe.com
April 10th 2025

Study Reveals Impact on Utilization and Cost of Point-of-Sale Diagnosis Verification of GLP-1s

Kennedy Ferruggia, Assistant Editor
FDA Clears Dexcom G7 15 Day, Marking the Longest-Lasting CGM System
April 10th 2025

FDA Clears Dexcom G7 15 Day, Marking the Longest-Lasting CGM System

Aislinn Antrim, Managing Editor